Proportional Estradiol Decline From Trigger to Retrieval Predicts Lower Clinical Pregnancy in Fresh GnRH Antagonist ICSI Cycles
A single-center retrospective cohort study of 849 fresh GnRH antagonist ICSI cycles found that a steeper proportional decline in serum estradiol from hCG trigger to oocyte retrieval was associated with lower clinical pregnancy rates despite comparable fertilization rates, top-quality embryo availability, and numbers of embryos transferred.
Researchers analyzed cycles from 727 patients and classified them by the percentage change in estradiol from trigger day to retrieval day: Group A with a decline of 45% or more (272 cycles), Group B with a decline greater than 30% to less than 45% (279 cycles), and Group C with a decline of 30% or less or an increase (298 cycles).
The primary outcome was clinical pregnancy confirmed by fetal cardiac activity. Overall, 391 of 849 cycles (46.1%) had a positive pregnancy test and 340 (40.0%) resulted in clinical pregnancy. Cycles that achieved clinical pregnancy showed a smaller median estradiol decline (-34.7%) compared with those that did not (-39.6%), a difference that was statistically significant (p < 0.001). In contrast, the absolute estradiol difference between trigger and retrieval did not differ significantly between the groups (p = 0.878).
Clinical pregnancy rates varied across the three groups: 30.5% in Group A, 45.5% in Group B, and 43.6% in Group C (p < 0.001). After multivariable adjustment, each 10-percentage-point increase in proportional estradiol change — meaning a smaller decline or a rise — was associated with an adjusted odds ratio of 1.090 for clinical pregnancy (95% confidence interval 1.005–1.183; p = 0.038). Analyses using generalized estimating equations to account for repeated cycles within the same patient yielded similar results. Spontaneous abortion rates were similar among the three groups.
The authors concluded that a more pronounced periovulatory estradiol decline remained modestly associated with lower odds of clinical pregnancy despite similar top-quality embryo availability, and suggested that proportional estradiol change may serve as a complementary marker of the periovulatory hormonal transition.